Mitchell Chan

AVTX

Mitchell Chan serves as director at Avalo Therapeutics, Inc. (AVTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$116.2K

Net Position

Net Seller

$116.2K

Companies Traded

AVTX, RGNX

Active Period

Sep 2025 – May 2026

2 total trades

Most Recent

Sell AVTX

May 7, 2026 · $72.5K

Mitchell Chan's Insider Trading at Avalo Therapeutics, Inc. (AVTX)

Buys

0 · $0.00

Sells

1 · $72.5K

Total Shares Bought

Total Shares Sold

3,167

AVTX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 7, 2026	Sell	3,167	$22.88	$72.5K	3,166

Mitchell Chan's Insider Trading at REGENXBIO Inc. (RGNX)

Buys

0 · $0.00

Sells

1 · $43.8K

Total Shares Bought

Total Shares Sold

4,901

RGNX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 1, 2025	Sell	4,901	$8.93	$43.8K	0

Related Insiders

Mittie Doyle

officer: Chief Medical Officer

AVTXSell · Jun 1, 2026

PAKOLA STEVE

officer: Chief Medical Officer

RGNXSell · May 13, 2026

Christopher Ryan Sullivan

officer: Chief Financial Officer

AVTXSell · May 11, 2026

VARKI PAUL

officer: Chief Legal Officer

AVTXSell · May 7, 2026

Patrick J. Christmas

Chief Strategy & Legal Officer

RGNXSell · Feb 1, 2026

Kenneth T. Mills

Director

RGNXSell · Jan 27, 2026

Craig Malzahn

Chief Technology Officer

RGNXSell · Jan 2, 2026

Curran Simpson

Chief Executive Officer

RGNXSell · Jan 2, 2026

Explore More Insider Trading Data

AVTX Insider Trading Activity

View all insider trades at Avalo Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity